Nu-Folic 5 mg Tablet is a Health Canada–registered human drug (DIN 02239233) held by Nu-Pharm Inc, containing Folic Acid. Health Canada lists its status as Cancelled (Unreturned Annual) (status date 28 Mar 2018). Nexara Health has matched 452 registrations of Folic Acid across 26 other regulated markets, 59 of them in the same strength and dosage form.

Health Canada registration

Folic Acid registered in other markets

452 registrations of the same molecule in 26 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Folic Acid worldwide →

Regulator price references for Folic Acid

Published list or reimbursement prices for Folic Acid presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Nu-Folic (DIN 02239233) marketed in Canada?

No. Health Canada lists DIN 02239233 as Cancelled (Unreturned Annual) as of 28 Mar 2018.

Who holds the Canadian licence for this product?

Nu-Pharm Inc is the company of record in the Health Canada Drug Product Database.

Is Folic Acid registered outside Canada?

Yes — Nexara Health has matched 452 registrations in 26 other markets, including 59 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02239233, status date 2018-03-28; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02239233, status date 2018-03-28; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS.

Health Canada Drug Product Database (DPD), DIN 02239233, status date 2018-03-28; national medicine registries: AIFA liste A/H, ANMDMR nomenclator, ARCSA registro sanitario, BDA, CMED, CNS liste positive, DH Drug Office, DoH SEP database, EDE, eEKO (Erstattungskodex), EMA centrally authorised, HPRA, LINAME (formulary), Medicines Authority, MISPAS, MoH deltio timwn, NHRA, NHS dm+d VMP, NPRA, PBS, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: AIFA liste A/H, CMED, EDE, eEKO (Erstattungskodex), MoH deltio timwn, NHRA, PBS. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.